Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (241-250 of 350) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
BCR rearrangement-negative chronic myelogenous leukemia revisitedR Kurzrock, C E Bueso-Ramos, H Kantarjian, et al.
Cancer Research|September 15, 1990
Constitutive and induced expression of growth factors in normal and chronic phase chronic myelogenous leukemia Ph1 bone marrow stromaM Wetzler, R Kurzrock, K Taylor, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 1, 1995
Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferationZ Estrov, B Samal, R Lapushin, et al.
Leukemia & Lymphoma|August 26, 1998
Serum cytokine levels in infectious mononucleosis at diagnosis and convalescenceV Wright-Browne, A M Schnee, M A Jenkins, et al.
Southern Medical Journal|October 1, 1987
Old age: a sign of poor prognosis in patients with chronic myelogenous leukemiaH M Kantarjian, M J Keating, K B McCredie, et al.
Cancer|April 1, 1988
Characteristics of accelerated disease in chronic myelogenous leukemiaH M Kantarjian, D Dixon, M J Keating, et al.
Leukemia|February 1, 1993
Suppression of chronic myelogenous leukemia colony growth by interleukin-4Z Estrov, A B Markowitz, R Kurzrock, et al.
Cancer|October 15, 1987
Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadronR S Walters, H M Kantarjian, M J Keating, et al.
The Journal of Clinical Investigation|November 1, 1990
A phosphatase activity present in peripheral blood myeloid cells of chronic myelogenous leukemia patients but not normal individuals alters nuclear protein binding to transcriptional enhancers of interferon-inducible genesD C Seong, S Sims, E Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 1999
Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award LectureH M Kantarjian, M Talpaz, S O'Brien, et al.
Pageof 35

Showing results (241-250 of 350) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
BCR rearrangement-negative chronic myelogenous leukemia revisitedR Kurzrock, C E Bueso-Ramos, H Kantarjian, et al.
Cancer Research|September 15, 1990
Constitutive and induced expression of growth factors in normal and chronic phase chronic myelogenous leukemia Ph1 bone marrow stromaM Wetzler, R Kurzrock, K Taylor, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 1, 1995
Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferationZ Estrov, B Samal, R Lapushin, et al.
Leukemia & Lymphoma|August 26, 1998
Serum cytokine levels in infectious mononucleosis at diagnosis and convalescenceV Wright-Browne, A M Schnee, M A Jenkins, et al.
Southern Medical Journal|October 1, 1987
Old age: a sign of poor prognosis in patients with chronic myelogenous leukemiaH M Kantarjian, M J Keating, K B McCredie, et al.
Cancer|April 1, 1988
Characteristics of accelerated disease in chronic myelogenous leukemiaH M Kantarjian, D Dixon, M J Keating, et al.
Leukemia|February 1, 1993
Suppression of chronic myelogenous leukemia colony growth by interleukin-4Z Estrov, A B Markowitz, R Kurzrock, et al.
Cancer|October 15, 1987
Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadronR S Walters, H M Kantarjian, M J Keating, et al.
The Journal of Clinical Investigation|November 1, 1990
A phosphatase activity present in peripheral blood myeloid cells of chronic myelogenous leukemia patients but not normal individuals alters nuclear protein binding to transcriptional enhancers of interferon-inducible genesD C Seong, S Sims, E Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 1999
Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award LectureH M Kantarjian, M Talpaz, S O'Brien, et al.
Pageof 35